BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed) · National Institutes of Health
MEDIUM confidence
Researched 2026-07-22 22:37 · profile: researcher
Programme Thesis
This BRAIN Initiative R61 mechanism funds exploratory, high-risk/high-reward research that uses invasive neural recording and stimulating technologies in humans to advance understanding of brain function and circuit dynamics. It exists to de-risk novel approaches and generate preliminary data for future larger-scale studies, with a strong emphasis on safety, feasibility, and technical innovation.
Selection Criteria
- Significance: Potential to advance understanding of human brain circuits and inform future therapies.
- Innovation: Novelty of the technology, paradigm, or analytical approach.
- Approach: Feasibility, safety plan, experimental design, and data analysis strategy.
- Investigator(s): Expertise in invasive human neuroscience, engineering, and relevant fields; track record of productivity.
- Environment: Access to clinical populations, surgical facilities, and necessary equipment.
- Scoring rubric: 1-9 scale on each criterion; overall impact score; priority given to projects with strong preliminary data and clear milestones.
Past Winners / Cohort Profiles
Typical awardees are established academic PIs (PhD or MD/PhD) at US institutions with prior experience in human intracranial recordings (e.g., epilepsy monitoring, DBS). Examples include teams from University of California, Stanford, Massachusetts General Hospital, and University of Pennsylvania. Projects often involve closed-loop stimulation, cognitive mapping, or motor decoding. Independent researchers without institutional affiliation are rare.
Ideal Candidate Fingerprint
A mid-career or senior investigator with a strong publication record in human invasive neurophysiology, affiliated with a major research hospital or university that provides access to neurosurgical patients. The applicant should have a clear track record of safely conducting human studies and a compelling, technically sound proposal that leverages existing infrastructure.
Recommended Framing
Eniola should position his CCT model and computational tools (IMPRINT, TOPOLOGIX, GATE) as a novel analytical framework for interpreting invasive neural data from human reward-circuit recordings. He can emphasize his collaborations with Berridge, Gershman, Daw, and Mattar as evidence of high-level scientific engagement, and propose a feasibility study using existing open-access human intracranial datasets (e.g., from epilepsy patients) to validate CCT predictions, thereby bypassing the need for direct surgical access.
Watch Out
No US institutional affiliation (NIH grants typically require a US-based institution as the applicant organization). No prior experience with invasive human neural recording or stimulation. Age and career stage (pre-PhD, independent researcher) are far outside the typical PI profile. The R61 mechanism explicitly disallows clinical trials, but the applicant's background is in pharmacology/computation, not direct human neurotechnology.